Change in PSA velocity is a predictor of overall survival in men with biochemically-recurrent prostate cancer treated with nonhormonal agents: combined analysis of four phase-2 trials

Change in PSA velocity is a predictor of overall survival in men with biochemically-recurrent prostate cancer treated with nonhormonal agents: combined analysis of four phase-2 trials Prostate Cancer and Prostatic Diseases advance online publication, November 11 2014. doi:10.1038/pcan.2014.44 Authors: D L Suzman, X C Zhou, M L Zahurak, J Lin & E S Antonarakis
Source: Prostate Cancer and Prostatic Diseases - Category: Urology & Nephrology Authors: Source Type: research